Sefa Burak Porgali

Sefa Burak Porgali

Auto-generated profile, based on publicly available information

Sefa Burak Porgali

Mustafa Kemal Univ, Fac Med, Dept Urol, Antakya, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2022 in Andrologia
Verified
Journal Article
Closed access
OKOmer Koras
Omer Koras
SGSADIK GÖRÜR
SADIK GÖRÜR
HBHanifi Bayramogulları
Hanifi Bayramogulları
GIGul Ilhan
Gul Ilhan
FGFatih Gokalp
Fatih Gokalp
SPSefa Burak Porgalı
Sefa Burak Porgalı

10 June 2022 in Journal of Urological Surgery
Verified
Journal Article
Closed access
ÖKÖmer Koraş
Ömer Koraş
FGFatih Gokalp
Fatih Gokalp
EYEkrem Yıldırak
Ekrem Yıldırak
HSHakan Sigva
Hakan Sigva
NTNezih Tamkaç
Nezih Tamkaç
SGSADIK GÖRÜR
SADIK GÖRÜR

27 September 2021 in International Journal Of Clinical Practice
Verified
Journal Article
Closed access
PDF file
FGFatih Gokalp
Fatih Gokalp
OKOmer Koras
Omer Koras
DGDidar Gursoy
Didar Gursoy
HSHakan Sigva
Hakan Sigva
SPSefa Burak Porgali
Sefa Burak Porgali
SGSADIK GÖRÜR
SADIK GÖRÜR
Background TRUS biopsy is the preferred method for diagnosing prostate cancer, but it can cause infectious complications that arise with the contribution of fluoroquinolone resistance. We aimed to explore the potential protective effect of a second rectal enema before biopsy. Methods Between January 2015 and December 2020, 419 patients were assessed retrospectively. Patients with a history of anticoagulant use, uncontrolled diabetes, urological surgery, prostate biopsy, or recent hospitalization or overseas travel, as well as those with previous prostatitis, were excluded from the study. The patients were subsequently divided into two groups: Group 1(n=223) had received one enema, on the morning of the biopsy, and Group 2(n=196) had received two, with the additional enema administered half an hour before the procedure. Results There was no significant difference between the groups in terms of age(p=0.076), BMI(p=0.489), diabetes(p=0.265), prostate-specific antigen(PSA) level(p=0.193), free/total PSA (f/t PSA) ratio(p=0.518), and prostate size(p=0.661) or in relation to cancer detection(p=0.428). The median hospitalization date was significantly higher in Group 1(p=0.003) as was urinary tract infection (UTI) development(p=0.004). However, there was no significant difference in terms of fever and sepsis(p=0.524andp=0.548,respectively). Additionally, subgroup analysis demonstrated that UTI was significantly lower in patients with diabetes mellitus who had received a second enema(p=0.004), though there was no significant difference in UTI between the groups in those without diabetes mellitus(p=0.215). Multivariable analysis showed that age and diabetes were significant risk factors for the development of UTI(OR:1.074,95%CI:1.027-1.130,p=0.002 and OR:1.220,95%CI:0.131-0.665,p=0.003, respectively). Furthermore, the second enema was a significant protective factor for preventing UTI(OR:-1.794,95%CI:2.208-16.389,p<0.001). Conclusion Older age and the presence of diabetes mellitus are independent risk factors for UTI after prostate biopsy. A second enema procedure before biopsy may protect patients from related infectious complications and could therefore be used as an alternative preventative method.